Optimal Management of Nontuberculous Mycobacterial Lung Disease: A Clinical Olympics Proceedings

Program Overview

RMEI proposes a gamified, team-oriented symposium at the 2022 Infectious Disease Society of America (ID Week) Annual Meeting in collaboration with the Array technology platform team, to drive learner engagement and retention. The Clinical Olympics theme will frame the event as a tongue-in-cheek competition for the “Healthiest Country” by responding to polling questions via iPads after choosing their country/team and logging on. Teams will compete in a series of “events” where learners from each team answer questions related to diagnosis and management of NTM-LD, including safety and efficacy of the various agents used for treatment, practical implementation of treatments, along with appropriate monitoring of treatment response.

1.00 CE Credit(s)

Expires: December 5, 2023

Target Audience

Infectious disease specialists, pulmonologists, geriatricians, primary care, and other clinicians who manage patients with nontuberculous mycobacterial lung disease (NTM-LD).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Identify patients who are at risk for developing NTM-LD
Diagnose patients with NTM-LD according to current criteria and established testing methods
Develop personalized treatment regimens for patients with NTM-LD

Activity Faculty

Pamela J. McShane, MD

Associate Professor of Medicine
Department of Medicine
Division of Pulmonary and Critical Care
The University of Texas at Tyler
Tyler, Texas

Charles L. Daley, MD

Chief, Division of Mycobacterial and Respiratory Infections
Professor of Medicine
National Jewish Health
Denver, Colorado

Kevin L. Winthrop, MD, MPH

Professor of Infectious Diseases, Ophthalmology
Professor of Public Health and Preventive Medicine (joint appointment)
Oregon Health and Science University
Portland, Oregon

Provider Statement

Provided by RMEI Medical Education, LLC

Supporter Statement

Supported by an educational grant from Insmed

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

Featured RMEI CE Activities